Recombinant PD-L1 antibody (AA 19-239)

Catalog No. ABIN7449160

This Rabbit Monoclonal antibody specifically detects PD-L1 in WB. It exhibits reactivity toward Mouse.

Quick Overview for Recombinant PD-L1 antibody (AA 19-239) (ABIN7449160)

Target: PD-L1 (CD274 (PD-L1))

Antibody Type: Recombinant Antibody

Reactivity: Mouse

Host: Rabbit

Clonality: Monoclonal

Conjugate: This PD-L1 antibody is un-conjugated

Application: Western Blotting (WB)

Clone: BLR226K

Product Details anti-PD-L1 Antibody

Binding Specificity: AA 19-239

Purpose: Rabbit anti-PD-L1 Recombinant Monoclonal Antibody [BLR226K]

Immunogen: residues 19-239 (ECD)

Isotype: IgG

Application Details

Application Notes: 01:01,00

Restrictions: For Research Use only

Handling

Concentration: 1000 μg/mL

Buffer: Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Expiry Date: 12 months

Target Details for PD-L1

Target: PD-L1 (CD274 (PD-L1))

Alternative Name: PD-L1

Background: Background: PD-L1 is an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. PD-L1 is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma [taken from NCBI Entrez Gene (Gene ID: 55193)].

Gene ID: 60533

NCBI Accession: NP_068693

UniProt: Q9EP73

Pathways: Cancer Immune Checkpoints